nodes	percent_of_prediction	percent_of_DWPC	metapath
Amobarbital—GRIA2—Unblocking of NMDA receptor, glutamate binding and activation—ACTN2—dilated cardiomyopathy	0.0484	0.0786	CbGpPWpGaD
Amobarbital—Ataxia—Spironolactone—dilated cardiomyopathy	0.0262	0.0683	CcSEcCtD
Amobarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—ACTN2—dilated cardiomyopathy	0.0239	0.0389	CbGpPWpGaD
Amobarbital—Mental disability—Furosemide—dilated cardiomyopathy	0.0181	0.0472	CcSEcCtD
Amobarbital—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.0161	0.0419	CcSEcCtD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.0158	0.0257	CbGpPWpGaD
Amobarbital—Confusional state—Spironolactone—dilated cardiomyopathy	0.0138	0.036	CcSEcCtD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.0129	0.0209	CbGpPWpGaD
Amobarbital—Somnolence—Spironolactone—dilated cardiomyopathy	0.0122	0.0317	CcSEcCtD
Amobarbital—GRIA2—N-cadherin signaling events—GJA1—dilated cardiomyopathy	0.012	0.0194	CbGpPWpGaD
Amobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.0117	0.019	CbGpPWpGaD
Amobarbital—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.0113	0.0294	CcSEcCtD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.0113	0.0183	CbGpPWpGaD
Amobarbital—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.0108	0.0282	CcSEcCtD
Amobarbital—Ataxia—Lisinopril—dilated cardiomyopathy	0.0107	0.0279	CcSEcCtD
Amobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.0107	0.0173	CbGpPWpGaD
Amobarbital—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.0101	0.0263	CcSEcCtD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00919	0.0149	CbGpPWpGaD
Amobarbital—GRIA2—N-cadherin signaling events—RAC1—dilated cardiomyopathy	0.00911	0.0148	CbGpPWpGaD
Amobarbital—Dizziness—Spironolactone—dilated cardiomyopathy	0.00907	0.0236	CcSEcCtD
Amobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00896	0.0145	CbGpPWpGaD
Amobarbital—GRIK2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00881	0.0143	CbGpPWpGaD
Amobarbital—Vomiting—Spironolactone—dilated cardiomyopathy	0.00872	0.0227	CcSEcCtD
Amobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00869	0.0141	CbGpPWpGaD
Amobarbital—Rash—Spironolactone—dilated cardiomyopathy	0.00865	0.0225	CcSEcCtD
Amobarbital—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00864	0.0225	CcSEcCtD
Amobarbital—Headache—Spironolactone—dilated cardiomyopathy	0.00859	0.0224	CcSEcCtD
Amobarbital—Agitation—Furosemide—dilated cardiomyopathy	0.0084	0.0219	CcSEcCtD
Amobarbital—Nausea—Spironolactone—dilated cardiomyopathy	0.00814	0.0212	CcSEcCtD
Amobarbital—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00802	0.0209	CcSEcCtD
Amobarbital—CHRNA7—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00801	0.013	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.00798	0.013	CbGpPWpGaD
Amobarbital—Hallucination—Lisinopril—dilated cardiomyopathy	0.00784	0.0204	CcSEcCtD
Amobarbital—GABRA6—Ion channel transport—RYR2—dilated cardiomyopathy	0.00765	0.0124	CbGpPWpGaD
Amobarbital—GABRA4—Ion channel transport—RYR2—dilated cardiomyopathy	0.00755	0.0123	CbGpPWpGaD
Amobarbital—Confusional state—Furosemide—dilated cardiomyopathy	0.00752	0.0196	CcSEcCtD
Amobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00745	0.0121	CbGpPWpGaD
Amobarbital—GABRA6—Ion channel transport—PLN—dilated cardiomyopathy	0.00744	0.0121	CbGpPWpGaD
Amobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00736	0.0119	CbGpPWpGaD
Amobarbital—GABRA4—Ion channel transport—PLN—dilated cardiomyopathy	0.00734	0.0119	CbGpPWpGaD
Amobarbital—Shock—Furosemide—dilated cardiomyopathy	0.00734	0.0191	CcSEcCtD
Amobarbital—GRIK2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00704	0.0114	CbGpPWpGaD
Amobarbital—Hypotension—Furosemide—dilated cardiomyopathy	0.00697	0.0181	CcSEcCtD
Amobarbital—GRIK2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00675	0.011	CbGpPWpGaD
Amobarbital—GRIA2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00673	0.0109	CbGpPWpGaD
Amobarbital—Tension—Lisinopril—dilated cardiomyopathy	0.00673	0.0175	CcSEcCtD
Amobarbital—GABRA5—Ion channel transport—RYR2—dilated cardiomyopathy	0.00671	0.0109	CbGpPWpGaD
Amobarbital—Nervousness—Lisinopril—dilated cardiomyopathy	0.00666	0.0173	CcSEcCtD
Amobarbital—Somnolence—Furosemide—dilated cardiomyopathy	0.00663	0.0173	CcSEcCtD
Amobarbital—GABRA3—Ion channel transport—RYR2—dilated cardiomyopathy	0.00659	0.0107	CbGpPWpGaD
Amobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00654	0.0106	CbGpPWpGaD
Amobarbital—CHRNA4—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00653	0.0106	CbGpPWpGaD
Amobarbital—GABRA5—Ion channel transport—PLN—dilated cardiomyopathy	0.00653	0.0106	CbGpPWpGaD
Amobarbital—GABRA2—Ion channel transport—RYR2—dilated cardiomyopathy	0.00647	0.0105	CbGpPWpGaD
Amobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00642	0.0104	CbGpPWpGaD
Amobarbital—GABRA3—Ion channel transport—PLN—dilated cardiomyopathy	0.00641	0.0104	CbGpPWpGaD
Amobarbital—CHRNA7—Neuronal System—ABCC9—dilated cardiomyopathy	0.0064	0.0104	CbGpPWpGaD
Amobarbital—Constipation—Furosemide—dilated cardiomyopathy	0.00638	0.0166	CcSEcCtD
Amobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00631	0.0102	CbGpPWpGaD
Amobarbital—GABRA2—Ion channel transport—PLN—dilated cardiomyopathy	0.0063	0.0102	CbGpPWpGaD
Amobarbital—Angioedema—Lisinopril—dilated cardiomyopathy	0.00627	0.0163	CcSEcCtD
Amobarbital—Syncope—Lisinopril—dilated cardiomyopathy	0.00615	0.016	CcSEcCtD
Amobarbital—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00615	0.016	CcSEcCtD
Amobarbital—CHRNA7—Neuronal System—ACTN2—dilated cardiomyopathy	0.00614	0.00997	CbGpPWpGaD
Amobarbital—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00603	0.0157	CcSEcCtD
Amobarbital—Body temperature increased—Furosemide—dilated cardiomyopathy	0.0059	0.0154	CcSEcCtD
Amobarbital—Anxiety—Lisinopril—dilated cardiomyopathy	0.00582	0.0151	CcSEcCtD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00569	0.00924	CbGpPWpGaD
Amobarbital—Confusional state—Lisinopril—dilated cardiomyopathy	0.00564	0.0147	CcSEcCtD
Amobarbital—GABRA6—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.0056	0.0091	CbGpPWpGaD
Amobarbital—GABRA4—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00553	0.00898	CbGpPWpGaD
Amobarbital—GABRA1—Ion channel transport—RYR2—dilated cardiomyopathy	0.00552	0.00896	CbGpPWpGaD
Amobarbital—Shock—Lisinopril—dilated cardiomyopathy	0.00551	0.0143	CcSEcCtD
Amobarbital—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.0055	0.0143	CcSEcCtD
Amobarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—RAF1—dilated cardiomyopathy	0.00544	0.00884	CbGpPWpGaD
Amobarbital—GRIA2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00538	0.00874	CbGpPWpGaD
Amobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00538	0.00873	CbGpPWpGaD
Amobarbital—GABRA1—Ion channel transport—PLN—dilated cardiomyopathy	0.00537	0.00872	CbGpPWpGaD
Amobarbital—Hypotension—Lisinopril—dilated cardiomyopathy	0.00523	0.0136	CcSEcCtD
Amobarbital—CHRNA4—Neuronal System—ABCC9—dilated cardiomyopathy	0.00522	0.00848	CbGpPWpGaD
Amobarbital—GRIA2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00516	0.00838	CbGpPWpGaD
Amobarbital—CHRNA4—Neuronal System—ACTN2—dilated cardiomyopathy	0.005	0.00813	CbGpPWpGaD
Amobarbital—Somnolence—Lisinopril—dilated cardiomyopathy	0.00498	0.013	CcSEcCtD
Amobarbital—Dizziness—Furosemide—dilated cardiomyopathy	0.00493	0.0128	CcSEcCtD
Amobarbital—GABRA5—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00491	0.00798	CbGpPWpGaD
Amobarbital—GABRA3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00483	0.00784	CbGpPWpGaD
Amobarbital—Constipation—Lisinopril—dilated cardiomyopathy	0.00479	0.0125	CcSEcCtD
Amobarbital—Vomiting—Furosemide—dilated cardiomyopathy	0.00474	0.0123	CcSEcCtD
Amobarbital—GABRA2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00474	0.0077	CbGpPWpGaD
Amobarbital—Rash—Furosemide—dilated cardiomyopathy	0.0047	0.0122	CcSEcCtD
Amobarbital—Dermatitis—Furosemide—dilated cardiomyopathy	0.0047	0.0122	CcSEcCtD
Amobarbital—Headache—Furosemide—dilated cardiomyopathy	0.00467	0.0122	CcSEcCtD
Amobarbital—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00461	0.012	CcSEcCtD
Amobarbital—GABRA6—Neuronal System—ABCC9—dilated cardiomyopathy	0.00448	0.00727	CbGpPWpGaD
Amobarbital—Nausea—Furosemide—dilated cardiomyopathy	0.00443	0.0115	CcSEcCtD
Amobarbital—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00442	0.0115	CcSEcCtD
Amobarbital—GABRA4—Neuronal System—ABCC9—dilated cardiomyopathy	0.00442	0.00718	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.0044	0.00715	CbGpPWpGaD
Amobarbital—GABRA6—Neuronal System—ACTN2—dilated cardiomyopathy	0.00429	0.00697	CbGpPWpGaD
Amobarbital—GABRA4—Neuronal System—ACTN2—dilated cardiomyopathy	0.00424	0.00688	CbGpPWpGaD
Amobarbital—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00412	0.0107	CcSEcCtD
Amobarbital—GABRA1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00404	0.00657	CbGpPWpGaD
Amobarbital—GABRA5—Neuronal System—ABCC9—dilated cardiomyopathy	0.00393	0.00638	CbGpPWpGaD
Amobarbital—GABRA3—Neuronal System—ABCC9—dilated cardiomyopathy	0.00386	0.00626	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00382	0.0062	CbGpPWpGaD
Amobarbital—GABRA2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00379	0.00615	CbGpPWpGaD
Amobarbital—GABRA5—Neuronal System—ACTN2—dilated cardiomyopathy	0.00377	0.00611	CbGpPWpGaD
Amobarbital—Dizziness—Lisinopril—dilated cardiomyopathy	0.0037	0.00963	CcSEcCtD
Amobarbital—GABRA3—Neuronal System—ACTN2—dilated cardiomyopathy	0.0037	0.006	CbGpPWpGaD
Amobarbital—GABRA2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00363	0.0059	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00359	0.00583	CbGpPWpGaD
Amobarbital—Vomiting—Lisinopril—dilated cardiomyopathy	0.00356	0.00926	CcSEcCtD
Amobarbital—Rash—Lisinopril—dilated cardiomyopathy	0.00353	0.00919	CcSEcCtD
Amobarbital—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00353	0.00918	CcSEcCtD
Amobarbital—Headache—Lisinopril—dilated cardiomyopathy	0.00351	0.00913	CcSEcCtD
Amobarbital—GRIA2—BDNF signaling pathway—RPS6KB1—dilated cardiomyopathy	0.00333	0.0054	CbGpPWpGaD
Amobarbital—Nausea—Lisinopril—dilated cardiomyopathy	0.00332	0.00865	CcSEcCtD
Amobarbital—GABRA1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00323	0.00525	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00311	0.00505	CbGpPWpGaD
Amobarbital—GABRA1—Neuronal System—ACTN2—dilated cardiomyopathy	0.0031	0.00503	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—RAC1—dilated cardiomyopathy	0.00301	0.00488	CbGpPWpGaD
Amobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00267	0.00433	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00266	0.00432	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00263	0.00427	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00259	0.0042	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00259	0.0042	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00256	0.00415	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00256	0.00415	CbGpPWpGaD
Amobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00242	0.00394	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00241	0.00391	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00238	0.00386	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00233	0.00379	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00229	0.00372	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00227	0.00369	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00227	0.00369	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00225	0.00366	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00223	0.00362	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00223	0.00362	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00222	0.00361	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00219	0.00356	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00219	0.00356	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00211	0.00343	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00207	0.00337	CbGpPWpGaD
Amobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00204	0.00331	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00204	0.00331	CbGpPWpGaD
Amobarbital—GRIK2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.002	0.00325	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—RAF1—dilated cardiomyopathy	0.00199	0.00324	CbGpPWpGaD
Amobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00198	0.00321	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00193	0.00313	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00192	0.00312	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00187	0.00303	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00187	0.00303	CbGpPWpGaD
Amobarbital—CHRNA7—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00182	0.00296	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00174	0.00282	CbGpPWpGaD
Amobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.0017	0.00275	CbGpPWpGaD
Amobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00167	0.00272	CbGpPWpGaD
Amobarbital—GRIK2—Neuronal System—RAF1—dilated cardiomyopathy	0.00154	0.00249	CbGpPWpGaD
Amobarbital—GRIA2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00153	0.00249	CbGpPWpGaD
Amobarbital—GABRA6—Ion channel transport—RAF1—dilated cardiomyopathy	0.00151	0.00245	CbGpPWpGaD
Amobarbital—GABRA4—Ion channel transport—RAF1—dilated cardiomyopathy	0.00149	0.00242	CbGpPWpGaD
Amobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00149	0.00241	CbGpPWpGaD
Amobarbital—CHRNA4—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00149	0.00241	CbGpPWpGaD
Amobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00146	0.00237	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.00145	0.00236	CbGpPWpGaD
Amobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00144	0.00233	CbGpPWpGaD
Amobarbital—CHRNA7—Neuronal System—RAF1—dilated cardiomyopathy	0.0014	0.00227	CbGpPWpGaD
Amobarbital—GABRA5—Ion channel transport—RAF1—dilated cardiomyopathy	0.00132	0.00215	CbGpPWpGaD
Amobarbital—GABRA3—Ion channel transport—RAF1—dilated cardiomyopathy	0.0013	0.00211	CbGpPWpGaD
Amobarbital—GABRA2—Ion channel transport—RAF1—dilated cardiomyopathy	0.00128	0.00207	CbGpPWpGaD
Amobarbital—GABRA6—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00127	0.00207	CbGpPWpGaD
Amobarbital—GABRA4—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00126	0.00204	CbGpPWpGaD
Amobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00122	0.00199	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.00118	0.00192	CbGpPWpGaD
Amobarbital—GRIA2—Neuronal System—RAF1—dilated cardiomyopathy	0.00117	0.00191	CbGpPWpGaD
Amobarbital—CHRNA4—Neuronal System—RAF1—dilated cardiomyopathy	0.00114	0.00185	CbGpPWpGaD
Amobarbital—GABRA5—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00112	0.00182	CbGpPWpGaD
Amobarbital—GABRA3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.0011	0.00178	CbGpPWpGaD
Amobarbital—GABRA1—Ion channel transport—RAF1—dilated cardiomyopathy	0.00109	0.00177	CbGpPWpGaD
Amobarbital—GABRA2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00108	0.00175	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ANKRD1—dilated cardiomyopathy	0.00106	0.00173	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—TAZ—dilated cardiomyopathy	0.001	0.00163	CbGpPWpGaD
Amobarbital—GABRA6—Neuronal System—RAF1—dilated cardiomyopathy	0.000976	0.00159	CbGpPWpGaD
Amobarbital—GABRA4—Neuronal System—RAF1—dilated cardiomyopathy	0.000964	0.00157	CbGpPWpGaD
Amobarbital—GABRA1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00092	0.00149	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—SDHA—dilated cardiomyopathy	0.000905	0.00147	CbGpPWpGaD
Amobarbital—GABRA5—Neuronal System—RAF1—dilated cardiomyopathy	0.000857	0.00139	CbGpPWpGaD
Amobarbital—GABRA3—Neuronal System—RAF1—dilated cardiomyopathy	0.000841	0.00137	CbGpPWpGaD
Amobarbital—GABRA2—Neuronal System—RAF1—dilated cardiomyopathy	0.000827	0.00134	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000733	0.00119	CbGpPWpGaD
Amobarbital—GABRA1—Neuronal System—RAF1—dilated cardiomyopathy	0.000705	0.00114	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000525	0.000852	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000518	0.000842	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000461	0.000748	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000452	0.000734	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000444	0.000722	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000379	0.000615	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GPX1—dilated cardiomyopathy	0.000246	0.000399	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CD36—dilated cardiomyopathy	0.000239	0.000389	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—AGT—dilated cardiomyopathy	0.000216	0.00035	CbGpPWpGaD
